➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Moodys
Harvard Business School
Johnson and Johnson
McKinsey

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Gasmotin


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Gasmotin?

Gasmotin is an investigational drug.

There have been 11 clinical trials for Gasmotin. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2014.

The most common disease conditions in clinical trials are Dyspepsia, Gastritis, and Constipation. The leading clinical trial sponsors are Daewoong Pharmaceutical Co. LTD., Huazhong University of Science and Technology, and Sumitomo Pharmaceutical (Suzhou) Co., Ltd.

There are forty-six US patents protecting this investigational drug and four hundred and sixty-four international patents.

Recent Clinical Trials for Gasmotin
TitleSponsorPhase
The Comparative Analysis Between Motilitone and Gasmotin for the Symptom Relief in Gallstone Patients With Functional DyspepsiaYonsei UniversityN/A
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)Daewoong Pharmaceutical Co. LTD.Phase 3
Efficacy and Safety of DWJ1252 in the Treatment of Functional DyspepsiaDaewoong Pharmaceutical Co. LTD.Phase 3

See all Gasmotin clinical trials

Clinical Trial Summary for Gasmotin

Top disease conditions for Gasmotin
Top clinical trial sponsors for Gasmotin

See all Gasmotin clinical trials

US Patents for Gasmotin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Gasmotin   Get Started Free Cellulose micropowder ASAHI KASEI KABUSHIKI KAISHA (Tokyo, JP)   Get Started Free
Gasmotin   Get Started Free Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor   Get Started Free
Gasmotin   Get Started Free Method for rapid testing allergy Shibaguchi; Hirotomo (Fukuoka-Shi, Fukuoka, JP)   Get Started Free
Gasmotin   Get Started Free Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small molecules CuRNA, Inc. (Miami, FL)   Get Started Free
Gasmotin   Get Started Free Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate The Scripps Research Institute (La Jolla, CA) Novartis AG (Basel, CH)   Get Started Free
Gasmotin   Get Started Free Prophylactic and/or therapeutic agent for fibromyalgia ONO PHARMACEUTICAL CO., LTD. (Osaka, JP)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Gasmotin

Drugname Country Document Number Estimated Expiration Related US Patent
Gasmotin European Patent Office EP3181616 2034-08-12   Get Started Free
Gasmotin Japan JP6216074 2034-08-12   Get Started Free
Gasmotin Japan JPWO2016024493 2034-08-12   Get Started Free
Gasmotin Taiwan TW201613646 2034-08-12   Get Started Free
Gasmotin Taiwan TWI572360 2034-08-12   Get Started Free
Gasmotin World Intellectual Property Organization (WIPO) WO2016024493 2034-08-12   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Merck
Moodys
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.